The relative expression of BBOX1-AS1 and PHF8 in four groups’ tumor samples demonstrated that BBOX1-AS1 knockdown effectively interfered with the promotion of BBOX1-AS1 and PHF8 induced by sorafenib (Figures 7H and 7I). The gene discussed is BBOX1; the disease is neoplasm.